Ironwood Pharma (IRWD) Tops Q4 EPS by 4c

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $94.2 thousand versus the consensus estimate of $86.2 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Wells Fargo cuts Netflix rating on engagement risk, weak slate